Press Contact
For media enquiries, please reach out to: contact@aspivix.com
All
- All
- Blog
- In the media
- Press releases
Aspivix Announces MHRA Approval for the Groundbreaking Cervical Stabilizer Carevix® for a painless contraceptive care in the United Kingdom
Epalinges, Switzerland – August 26, 2024 - In a significant stride towards transforming women's healthcare, Aspivix, a leading innovator in gynecological solutions, is thrilled to announce that its pioneering device, Carevix®, has...
IUD insertion pain is complicated. Doctors say the new CDC guidelines are only a start.
Featured article on NBC News The CDC has updated its guidelines on pain management during IUD insertion, recommending pre-procedure counseling and expanding pain relief options to include topical lidocaine (gels or sprays)...
Femtech Companies to Watch in 2024
From devices and diagnostics to digital health, these femtech companies breathe innovation. Femtech is finally getting its well-deserved time in the limelight as innovative women-led products hit the medtech stage. There are...
IUD Insertion Is Often Painful—Can a New Tool Help? feature on Health.com
This article focuses on our new device, Carevix®, designed to reduce pain during IUD insertion. Traditional IUD insertion uses a tenaculum to grasp the cervix, which can cause pain and uterine contractions....
Aspivix and Xemperia both receive support from FIT
The Foundation for Technological Innovation is pleased to announce two new loans to Aspivix and Xemperia. Aspivix has been awarded a Tech Growth loan of CHF 500,000 for its non-traumatic device for...
Yuka, WeWard and Aspivix: winners of the 15th French American Entrepreneurship Award
NEW YORK--(BUSINESS WIRE)--The French American Entrepreneurship Award (FAEA) has concluded its 15th year by recognizing three exceptional early-stage startups led by French entrepreneurs in the US. Since 2008, the FAEA has supported...
